Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality

Award Number: R01HL135920
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2017
PERIOD OF PERFORMANCE END DATE: 01/31/2028

Group Awards By:

View Award Description

Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality - The host diet and gut microbiome combine to produce a range of microbiome-generated plasma metabolites that influence human health. Characterizing these metabolites and their relationships with major disease endpoints is critical to elucidate new pathways of risk and corresponding novel preventive and pharmacologic treatments. Phenylalanine, tyrosine, and tryptophan are the three aromatic amino acids (AAA), centrally involved in protein synthesis and metabolized to a range of bioactive compounds. Gut microbial enzymes ferment AAA into a plethora of small molecules via deamination, oxidation, and/or reduction. The gut microbe-derived metabolites can be further metabolized by host liver enzymes before they reach systemic circulation. Several AAA-derived microbial metabolites have been previously identified as of potential interest in human health, such as indole-3-propionic acid (I3PA), derived from microbial metabolism of tryptophan and implicated in diet induced obesity, advanced atherosclerosis, gut permeability, and brain health. However, the health effects of this and other AAA-derived microbial metabolites remain understudied. This project resubmission will leverage the power of serial biomarkers measures to investigate the interrelationships of novel microbiome-generated AAA metabolites with initiation, extent, and clinical onset of subclinical CVD, clinical CHD, and total mortality. Primary aims include: (1) To investigate the independent relationships of serial measures of plasma aromatic amino acid (AAA)-derived microbial metabolites with longitudinal onset and progression of subclinical CVD. (2) To investigate the independent relationships of serial measures of plasma AAA-derived microbial metabolites with incident CVD events. (3) To investigate the independent relationships of serial measures of plasma AAA-derived microbial metabolites with total mortality. Secondary Aims include focuses to investigate (a) the independent dietary, lifestyle, and demographic predictors of plasma AAA-derived microbial metabolites and change in these metabolites over time in two diverse community-based populations; and (b) potential effect modification of metabolite-outcome associations by age, sex, race/ethnicity, socioeconomic status, background diet, lipid-lowering medication use, renal function, and prevalent CVD. This project will provide novel, impactful evidence on how AAA-derived microbial metabolites, measured serially over time, relate to subclinical CVD, clinical CVD, and mortality in the Multi-Ethnic Study of Atherosclerosis (MESA; 6,800 middle-aged white, Black, Hispanic, and Chinese adults) and the Cardiovascular Health Study (CHS; 5,148 older white and Black adults). In pilot work, we have evaluated the long-term reproducibility of these AAA analytes using serial blood samples collected at baseline (year 2) and 9 years later (year 11) in a random subset of 100 CHS participants.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,301,344 )
2026	2026	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	7	4/27/2026	NON-COMPETING CONTINUATION	$1,301,344
														Subtotal = $1,301,344

Issue Date FY: 2025 ( Subtotal = $1,327,902 )
2025	2025	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	001	6	7/17/2025	NON-COMPETING CONTINUATION	$132,791
2025	2025	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	6	3/5/2025	NON-COMPETING CONTINUATION	$1,195,111
														Subtotal = $1,327,902

Issue Date FY: 2024 ( Subtotal = $1,378,637 )
2024	2024	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	5	2/12/2024	COMPETING CONTINUATION	$1,378,637
														Subtotal = $1,378,637

Issue Date FY: 2023 ( Subtotal = -$7,645 )
2023	2020	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	4	2/2/2023	NON-COMPETING CONTINUATION	-$7,645
														Subtotal = -$7,645

Issue Date FY: 2020 ( Subtotal = $1,147,817 )
2020	2020	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	4	4/30/2020	NON-COMPETING CONTINUATION	$1,147,817
														Subtotal = $1,147,817

Issue Date FY: 2019 ( Subtotal = $1,145,137 )
2019	2019	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	3	5/23/2019	NON-COMPETING CONTINUATION	$1,145,137
														Subtotal = $1,145,137

Issue Date FY: 2018 ( Subtotal = $1,151,732 )
2018	2018	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	2	5/15/2018	NON-COMPETING CONTINUATION	$1,151,732
														Subtotal = $1,151,732

Issue Date FY: 2017 ( Subtotal = $1,207,201 )
2017	2017	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Cardiovascular Diseases Research	000	1	6/19/2017	NEW	$1,207,201
														Subtotal = $1,207,201

Grand Total All Awards = $8,652,125

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality

Award Number: R01HL135920

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2017

PERIOD OF PERFORMANCE END DATE: 01/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer